Orion Biotech Opportuniti... (ORIA)
NASDAQ: ORIA
· Real-Time Price · USD
10.23
0.00 (0.00%)
At close: May 04, 2023, 4:04 PM
Company Description
Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities.
The company was founded in 2021 and is based in New York, New York.
Orion Biotech Opportunities Corp.
| Country | United States |
| IPO Date | Jul 2, 2021 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Zuie-Chin Huang |
Contact Details
Address: 645 Fifth Avenue New York City, New York United States | |
| Website | https://orionbiotechopportunities.com |
Stock Details
| Ticker Symbol | ORIA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001847416 |
| CUSIP Number | G6780C109 |
| ISIN Number | KYG6780C1096 |
| Employer ID | 00-0000000 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Zuie-Chin Huang M.B.A. | Chief Executive Officer & Director |
| Mark Kayal | Chief Financial Officer & Sec. |
| Robert Kenneth Simonds | Gen. Counsel, Assistant Sec., Vice President & Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| May 18, 2023 | 4 | Filing |
| May 18, 2023 | 4 | Filing |
| May 18, 2023 | 4 | Filing |
| May 18, 2023 | 4 | Filing |
| May 11, 2023 | 15-12G | Filing |
| May 01, 2023 | 25 | Filing |
| Apr 24, 2023 | 8-K | Current Report |
| Mar 29, 2023 | 10-K | Annual Report |
| Nov 10, 2022 | 10-Q | Quarterly Report |